Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Bolsa de Madrid  >  Almirall SA    ALM   ES0157097017

ALMIRALL SA (ALM)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bolsa De Madrid
07/16/2018 07/17/2018 07/18/2018 07/19/2018 07/20/2018 Date
11.81(c) 11.9(c) 12.04(c) 11.7(c) 11.6(c) Last
220 313 297 571 402 301 252 125 348 378 Volume
-0.67% +0.76% +1.18% -2.82% -0.85% Change
More quotes
Financials (EUR)
Sales 2018 706 M
EBIT 2018 95,9 M
Net income 2018 66,7 M
Finance 2018 72,7 M
Yield 2018 1,53%
Sales 2019 748 M
EBIT 2019 122 M
Net income 2019 99,2 M
Finance 2019 74,8 M
Yield 2019 1,57%
P/E ratio 2018 31,24
P/E ratio 2019 21,38
EV / Sales2018 2,75x
EV / Sales2019 2,60x
Capitalization 2 017 M
More Financials
Company
Almirall SA engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production.The company operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research... 
Sector
Pharmaceuticals
Calendar
07/30Earnings Release
More about the company
Surperformance© ratings of Almirall SA
Trading Rating : Investor Rating :
More Ratings
Latest news on ALMIRALL SA
06/19ALMIRALL : seeks new compounds to improve skin health
PU
05/16ALMIRALL SA : Ex-dividend day for Cash amount paid with the scrip issue offered ..
FA
05/14ALMIRALL : Q1 2018. Encouraging Financial Results
PU
05/09ALMIRALL SA : quaterly earnings release
05/03ALMIRALL : Using bioactivity profiling to support the progression of phenotypic ..
AQ
04/18ALMIRALL : European dermatologists discuss the newest therapies and innovations ..
PU
03/27ATHENEX : Announces Fourth Quarter and Full-Year 2017 Results
AQ
03/19EISAI : Launches gastrointestinal prokinetic agent cidine in china
AQ
02/23ALMIRALL : Full-Year 2017 Results
PU
02/21ALMIRALL SA : annual earnings release
More news
Sector news : Pharmaceuticals - NEC
10:43aCHINA'S LATEST CONSUMER SCANDAL : Unsafe Vaccines
DJ
08:16aSHIRE PLC SHIRE PLC : Notice Of Results
DJ
07/20GLAXOSMITHKLINE : considers splitting up the group - FT
RE
07/20PFIZER : Biosimilar of Amgen's Neupogen Approved for Sale in the U.S.
DJ
07/20BAYER : to Stop Selling Essure in U.S.
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
06/19Almirall : seeks new compounds to improve skin health  
06/16TheScreener - ALMIRALL SA with less fundamental stars is reduced to Neutral: .. 
05/16Bankinter Securities - S.A. Almirall 1Q18 results: flat sales but lower cost.. 
05/10$ALM SA Almirall 1Q18 preview: Earnings to decline on flat total income: Alm.. 
04/18Almirall : European dermatologists discuss the newest therapies and innovatio.. 
More tweets
Qtime:109
News from SeekingAlpha
05/15Almirall SA 2018 Q1 - Results - Earnings Call Slides 
02/27Almirall SA 2017 Q4 - Results - Earnings Call Slides 
2017COBAS ASSET MANAGEMENT : Comments On Third Quarter 2017 
2017Almirall SA 2017 Q3 - Results - Earnings Call Slides 
2017Almirall SA 2017 Q3 - Results - Earnings Call Slides 
Chart ALMIRALL SA
Duration : Period :
Almirall SA Technical Analysis Chart | 4-Traders
Full-screen chart
Technical analysis trends ALMIRALL SA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Average target price 11,2 €
Spread / Average Target -3,1%
EPS Revisions
Managers
NameTitle
Peter Guenter Chief Executive Officer & Director
Jorge Gallardo Ballart Chairman
David Nieto Chief Financial Officer
Eloi Crespo Cervera Vice President-Manufacturing & Technical Services
Bhushan D. Hardas Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
ALMIRALL SA38.92%2 384
JOHNSON & JOHNSON-9.93%337 790
PFIZER3.06%218 540
NOVARTIS-0.24%206 705
ROCHE HOLDING LTD.-5.07%200 737
MERCK AND COMPANY11.11%168 171